10th Aggregate Spend and Open Payments Conference – 10th Aggregate Spend and Open Payments Conference

The demand for transparency when looking at the relationship between life science manufacturers and health care providers is at an all-time high. Recent updates to the Physicians Payments Sunshine Act will increase the scope of responsibilities for manufacturers and HCPs alike. The current landscape surrounding aggregate spend and the open payments system also involves the discussion of conflicts of interest, ethical interactions, and federal enforcement.

Interactions with HCPs can provide tremendous value to life science manufacturers but also presents risks for provider disputes or legal violations. Enforcement in the industry is constantly evolving on state, federal and global levels. With differences in reporting requirements, it is up to manufacturers to manage risk, maintain transparency and ensure compliance at all times, which can be extremely difficult. ExL Events is proud to bring you the 10th Aggregate Spend and Open Payments Conference. Over the past nine years, we have had the privilege of educating over 223 organizations and will continue to provide thought-provoking sessions, interactive panels, and spotlight sessions this year.

Top Five Reasons to Attend

  1. Explore Sunshine Act and Open Payments System updates with the Centers for Medicare and Medicaid Services Director, Robin Usi
  2. Interact with DOJ representatives and in-house counsel members to discuss the current enforcement landscape
  3. Gain insight from 20+ expert speakers from various backgrounds, including speakers from Boehringer Ingelheim, Daiichi Sankyo, Bayer, Otsuka, Chiesi, Shinogi and more
  4. Discuss the best practices for identifying, collecting, and analyzing the data required for open payments reporting
  5. Investigate emerging trends and high-risk areas including federal, state and global policies, privacy implications, price transparency, and ethical considerations

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology, and medical device companies and advocacy groups with responsibilities in the following areas:

  • Aggregate Spend
  • Compliance
  • Transparency
  • Corporate/Regulatory/Risk Compliance and Ethics
  • Government/Federal/State Reporting
  • Legal and Regulatory Affairs
  • Transparency Spend Reporting
  • Business Analysis and Development
  • Finance and Accounting
  • Financial Management Analytics
  • Data Management
  • Professional Affairs
  • Sales and Marketing
  • Commercial Operations
  • Clinical Operations/Disclosure
  • Medical Affairs
  • Contract Administrators
  • Grant Writing
  • Internal and External Training
  • Engagement

This conference is also of interest to:

  • Sunshine Reporting Solution Providers
  • Data Management Solution Providers
  • Complaisance Solution Providers
  • Transparency Reporting Solution Providers